in December 2024 the FDA's Pharmacy Compounding Advisory Committee voted against adding it to the final 503A bulks list, citing nonclinical toxicity, an unresolved cardiac signal, and immunogenicity risk
As noted earlier, more of the GLP-1 users showed improvement, and consequently more of the non-user group showed worsened disease (46% vs 29%)
If more than three days have passed, skip the missed dose and take your next dose on your normal injection day
Many pharmacies can process an emergency supply at a local branch near your destination
Tirzepatide can be prescribed today, while retatrutide, though very promising, is still in clinical trials and not yet approved
Lean Proteins Proteins are important for keeping muscle